KalVista Pharmaceuticals
KALV
#6541
Rank
A$0.88 B
Marketcap
$17.71
Share price
-5.39%
Change (1 day)
4.10%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -$4.74

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$5.23. In 2022 the company made an earnings per share (EPS) of -$6.19 a decrease over its 2021 EPS that were of -$4.42.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.74-23.3%
2022-$6.1940.07%
2021-$4.4228.37%
2020-$3.4441.5%
2019-$2.4318.55%
2018-$2.05-49.8%
2017-$4.09
2015-$25.01-6.99%
2014-$26.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.61-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA